FDA Inspection 1282032 — Bluebonnett Ethical Review IRB
The FDA completed an inspection of Bluebonnett Ethical Review IRB on Aug 28, 2025 in Lockhart, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 28, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Lockhart, TX (United States)
Additional Details
IRB